Showing results (1411-1420 of 1,476) with videos related to

Sort By:
Pageof 148
BJU International|June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlatesAndrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
CA: a Cancer Journal for Clinicians|October 28, 2022
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancerJung Julie Kang, Yao Yu, Linda Chen, et al.
American Journal of Cancer Research|January 8, 2024
Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registryChou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, et al.
Oral Oncology|April 26, 2023
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavityYao Yu, Heiko Schöder, Kaveh Zakeri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2020
Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort studyChia-Hsin Lin, Wen-Chi Chou, Yao-Yu Wu, et al.
Nutrients|July 14, 2023
Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching StudyYu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, et al.
Environment International|September 11, 2020
Is PM1 similar to PM2.5? A new insight into the association of PM1 and PM2.5 with children's lung functionMo Yang, Yu-Ming Guo, Michael S Bloom, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Prostate Cancer and Prostatic Diseases|July 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibitionAndrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, et al.
Oral Oncology|March 18, 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersDan Fan, Jung J Kang, Ming Fan, et al.
Pageof 148